COVID-19 risk mitigation in reopening mass cultural events : population-based observational study for the UK Events Research Programme in Liverpool City Region
OBJECTIVES: To understand severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission risks, perceived risks and the feasibility of risk mitigations from experimental mass cultural events before coronavirus disease 2019 (COVID-19) restrictions were lifted.
DESIGN: Prospective, population-wide observational study.
SETTING: Four events (two nightclubs, an outdoor music festival and a business conference) open to Liverpool City Region UK residents, requiring a negative lateral flow test (LFT) within the 36 h before the event, but not requiring social distancing or face-coverings.
PARTICIPANTS: A total of 12,256 individuals attending one or more events between 28 April and 2 May 2021.
MAIN OUTCOME MEASURES: SARS-CoV-2 infections detected using audience self-swabbed (5-7 days post-event) polymerase chain reaction (PCR) tests, with viral genomic analysis of cases, plus linked National Health Service COVID-19 testing data. Audience experiences were gathered via questionnaires, focus groups and social media. Indoor CO2 concentrations were monitored.
RESULTS: A total of 12 PCR-positive cases (likely 4 index, 8 primary or secondary), 10 from the nightclubs. Two further cases had positive LFTs but no PCR. A total of 11,896 (97.1%) participants with scanned tickets were matched to a negative pre-event LFT: 4972 (40.6%) returned a PCR within a week. CO2 concentrations showed areas for improving ventilation at the nightclubs. Population infection rates were low, yet with a concurrent outbreak of >50 linked cases around a local swimming pool without equivalent risk mitigations. Audience anxiety was low and enjoyment high.
CONCLUSIONS: We observed minor SARS-CoV-2 transmission and low perceived risks around events when prevalence was low and risk mitigations prominent. Partnership between audiences, event organisers and public health services, supported by information systems with real-time linked data, can improve health security for mass cultural events.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:117 |
---|---|
Enthalten in: |
Journal of the Royal Society of Medicine - 117(2024), 1 vom: 07. Jan., Seite 11-23 |
Sprache: |
Englisch |
---|
Links: |
---|
Themen: |
142M471B3J |
---|
Anmerkungen: |
Date Completed 14.02.2024 Date Revised 20.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1177/01410768231182389 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM358532884 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM358532884 | ||
003 | DE-627 | ||
005 | 20240320233220.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1177/01410768231182389 |2 doi | |
028 | 5 | 2 | |a pubmed24n1337.xml |
035 | |a (DE-627)NLM358532884 | ||
035 | |a (NLM)37351911 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Burnside, Girvan |e verfasserin |4 aut | |
245 | 1 | 0 | |a COVID-19 risk mitigation in reopening mass cultural events |b population-based observational study for the UK Events Research Programme in Liverpool City Region |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 14.02.2024 | ||
500 | |a Date Revised 20.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a OBJECTIVES: To understand severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission risks, perceived risks and the feasibility of risk mitigations from experimental mass cultural events before coronavirus disease 2019 (COVID-19) restrictions were lifted | ||
520 | |a DESIGN: Prospective, population-wide observational study | ||
520 | |a SETTING: Four events (two nightclubs, an outdoor music festival and a business conference) open to Liverpool City Region UK residents, requiring a negative lateral flow test (LFT) within the 36 h before the event, but not requiring social distancing or face-coverings | ||
520 | |a PARTICIPANTS: A total of 12,256 individuals attending one or more events between 28 April and 2 May 2021 | ||
520 | |a MAIN OUTCOME MEASURES: SARS-CoV-2 infections detected using audience self-swabbed (5-7 days post-event) polymerase chain reaction (PCR) tests, with viral genomic analysis of cases, plus linked National Health Service COVID-19 testing data. Audience experiences were gathered via questionnaires, focus groups and social media. Indoor CO2 concentrations were monitored | ||
520 | |a RESULTS: A total of 12 PCR-positive cases (likely 4 index, 8 primary or secondary), 10 from the nightclubs. Two further cases had positive LFTs but no PCR. A total of 11,896 (97.1%) participants with scanned tickets were matched to a negative pre-event LFT: 4972 (40.6%) returned a PCR within a week. CO2 concentrations showed areas for improving ventilation at the nightclubs. Population infection rates were low, yet with a concurrent outbreak of >50 linked cases around a local swimming pool without equivalent risk mitigations. Audience anxiety was low and enjoyment high | ||
520 | |a CONCLUSIONS: We observed minor SARS-CoV-2 transmission and low perceived risks around events when prevalence was low and risk mitigations prominent. Partnership between audiences, event organisers and public health services, supported by information systems with real-time linked data, can improve health security for mass cultural events | ||
650 | 4 | |a Observational Study | |
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a SARS-CoV-2 transmission | |
650 | 4 | |a cultural events | |
650 | 4 | |a mass gatherings | |
650 | 4 | |a respiratory virus risk mitigation | |
650 | 7 | |a Carbon Dioxide |2 NLM | |
650 | 7 | |a 142M471B3J |2 NLM | |
700 | 1 | |a Cheyne, Christopher P |e verfasserin |4 aut | |
700 | 1 | |a Leeming, Gary |e verfasserin |4 aut | |
700 | 1 | |a Humann, Michael |e verfasserin |4 aut | |
700 | 1 | |a Darby, Alistair |e verfasserin |4 aut | |
700 | 1 | |a Green, Mark A |e verfasserin |4 aut | |
700 | 1 | |a Crozier, Alexander |e verfasserin |4 aut | |
700 | 1 | |a Maskell, Simon |e verfasserin |4 aut | |
700 | 1 | |a O'Halloran, Kay |e verfasserin |4 aut | |
700 | 1 | |a Musi, Elena |e verfasserin |4 aut | |
700 | 1 | |a Carmi, Elinor |e verfasserin |4 aut | |
700 | 1 | |a Khan, Naila |e verfasserin |4 aut | |
700 | 1 | |a Fisher, Debra |e verfasserin |4 aut | |
700 | 1 | |a Corcoran, Rhiannon |e verfasserin |4 aut | |
700 | 1 | |a Dunning, Jake |e verfasserin |4 aut | |
700 | 1 | |a Edmunds, W John |e verfasserin |4 aut | |
700 | 1 | |a Tharmaratnam, Kukatharmini |e verfasserin |4 aut | |
700 | 1 | |a Hughes, David M |e verfasserin |4 aut | |
700 | 1 | |a Malki-Epshtein, Liora |e verfasserin |4 aut | |
700 | 1 | |a Cook, Malcolm |e verfasserin |4 aut | |
700 | 1 | |a Roberts, Ben M |e verfasserin |4 aut | |
700 | 1 | |a Gallagher, Eileen |e verfasserin |4 aut | |
700 | 1 | |a Howell, Kate |e verfasserin |4 aut | |
700 | 1 | |a Chand, Meera |e verfasserin |4 aut | |
700 | 1 | |a Kemp, Robin |e verfasserin |4 aut | |
700 | 1 | |a Boulter, Matthew |e verfasserin |4 aut | |
700 | 1 | |a Fowler, Tom |e verfasserin |4 aut | |
700 | 1 | |a Semple, Malcolm G |e verfasserin |4 aut | |
700 | 1 | |a Coffey, Emer |e verfasserin |4 aut | |
700 | 1 | |a Ashton, Matt |e verfasserin |4 aut | |
700 | 0 | |a COVID-19 Genomics UK (COG-UK) Consortium |e verfasserin |4 aut | |
700 | 1 | |a García-Fiñana, Marta |e verfasserin |4 aut | |
700 | 1 | |a Buchan, Iain E |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of the Royal Society of Medicine |d 1978 |g 117(2024), 1 vom: 07. Jan., Seite 11-23 |w (DE-627)NLM00025701X |x 1758-1095 |7 nnns |
773 | 1 | 8 | |g volume:117 |g year:2024 |g number:1 |g day:07 |g month:01 |g pages:11-23 |
856 | 4 | 0 | |u http://dx.doi.org/10.1177/01410768231182389 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 117 |j 2024 |e 1 |b 07 |c 01 |h 11-23 |